August Bioservices Expands Operations in Nashville
Plans to invest $64.7 million and create 180 jobs over the next five years.
Entries by Laura Harris
R&D Outsourcing Trends
Highly specialized drug products and capacity needs drive increased reliance on contract service providers.
Cobra Biologics to Manufacture Plasmids for COVID-19 Vax Trial
Collaboration will ensure GMP production of material for Phase I clinical trial of Scancell’s DNA vaccine against SARS-CoV-2.
August Bioservices Begins Major Expansion
To add large-scale lyophilization and sterile fill-finish capabilities to its clinical and commercial manufacturing offering.
PMI BioPharma Rebrands to August Bioservices
Closes investment from Oak HC/FT to accelerate growth; Jenn Adams named chief executive officer.
The New Wave of Innovation
Cell and gene therapies represent the new wave of innovation in the life sciences industry